ASLAN Pharmaceuticals Ltd (ASLN)
0.427
-0.02
(-4.50%)
USD |
NASDAQ |
May 06, 12:02
ASLAN Pharmaceuticals Net Income (TTM): -44.22M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -44.22M |
| September 30, 2023 | -45.19M |
| June 30, 2023 | -46.41M |
| March 31, 2023 | -57.56M |
| December 31, 2022 | -51.38M |
| September 30, 2022 | -45.77M |
| June 30, 2022 | -43.40M |
| March 31, 2022 | -35.79M |
| December 31, 2021 | -29.57M |
| September 30, 2021 | -26.42M |
| June 30, 2021 | -21.34M |
| March 31, 2021 | -19.87M |
| December 31, 2020 | -16.20M |
| September 30, 2020 | -40.04M |
| June 30, 2020 | -41.75M |
| Date | Value |
|---|---|
| March 31, 2020 | -45.72M |
| December 31, 2019 | -47.02M |
| September 30, 2019 | -28.65M |
| June 30, 2019 | -34.69M |
| March 31, 2019 | -37.80M |
| December 31, 2018 | -42.25M |
| September 30, 2018 | -45.59M |
| June 30, 2018 | -42.29M |
| March 31, 2018 | -40.44M |
| December 31, 2017 | -39.92M |
| September 30, 2017 | -32.16M |
| June 30, 2017 | -18.98M |
| March 31, 2017 | -13.13M |
| December 31, 2016 | -8.821M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-57.56M
Minimum
Mar 2023
-16.20M
Maximum
Dec 2020
-37.95M
Average
-41.75M
Median
Jun 2020
Net Income (TTM) Benchmarks
| Dr Reddy's Laboratories Ltd | 632.08M |
| Concord Medical Services Holdings Ltd | -41.69M |
| WAVE Life Sciences Ltd | -57.51M |
| Zai Lab Ltd | -334.62M |
| CytoMed Therapeutics Ltd | -3.074M |